Hemp has one FDA-approved medical use: a purified CBD extract called Epidiolex, prescribed to control seizures in rare forms of epilepsy. Beyond that single approved medication, hemp-derived CBD is widely used for pain, anxiety, and sleep, though most of these applications lack the same level of regulatory backing. Understanding the difference between what’s proven and what’s promising helps you evaluate whether hemp-based products might be relevant to your situation.
First, an important distinction. Hemp is legally defined in the United States as cannabis containing no more than 0.3% THC by dry weight. The medically active compound in most hemp products is CBD, which comes from the plant’s flowers, leaves, and stems. Hemp seed oil, by contrast, is a nutritional product pressed from the seeds. It contains omega-3 and omega-6 fatty acids, B vitamins, and vitamin D, but virtually no CBD or THC. If you’re looking at hemp for a health condition, you need a CBD extract, not hemp seed oil.
Seizure Control: The Strongest Evidence
The clearest medical application for hemp is treating severe epilepsy. The FDA approved Epidiolex, a pharmaceutical-grade CBD, for seizures associated with Lennox-Gastaut syndrome, Dravet syndrome, and tuberous sclerosis complex in patients one year of age and older. These are rare, treatment-resistant conditions where standard medications often fall short.
Clinical trials showed meaningful results. Patients receiving 20 mg of CBD per kilogram of body weight experienced a median 41.9% reduction in seizure frequency, while a lower 10 mg dose produced a 37.2% reduction. The placebo group saw only a 17% drop. That gap is significant for people living with dozens or hundreds of seizures per month.
Anxiety and Sleep
Anxiety is one of the most common reasons people turn to hemp-derived CBD, and clinical evidence supports this use at specific doses. Studies consistently show that CBD reduces anxiety at oral doses of 300 to 400 mg. Lower doses have not reliably produced the same effect in controlled trials, which is worth noting since many over-the-counter CBD products contain far less per serving.
Sleep is a more complicated picture. One study found that 160 mg of CBD improved sleep quality in people with insomnia, but doses of 40 or 80 mg did not. A separate study using 300 mg in healthy volunteers found no improvement in sleep quality or sleep architecture when measured with objective monitoring equipment. There is some evidence that CBD at 75 mg helps with REM sleep behavior disorder, a condition where people physically act out their dreams. Overall, the sleep data is inconsistent, and the effective dose seems to vary depending on the underlying problem.
Pain and Inflammation
CBD interacts with several systems in the body involved in pain signaling. It activates certain temperature-sensitive ion channels at very low concentrations, which are part of how your nervous system detects and transmits pain signals. It also appears to boost your body’s own endocannabinoid molecules by slowing their breakdown, essentially amplifying a pain-regulation system you already have. In animal studies, CBD injected into a brain region involved in pain processing produced dose-dependent pain relief.
CBD also works as an anti-inflammatory through multiple pathways. It enhances the activity of internal antioxidant defense systems and affects serotonin receptors involved in pain perception. These mechanisms are well-documented in laboratory and animal research. Human clinical data on pain is less definitive, with most trials using relatively small groups of participants, but the biological plausibility is strong enough that research continues at a significant pace.
Neuroprotective Properties
Some of the most intriguing research on hemp involves protecting nerve cells from damage. CBD acts as an antioxidant, but not simply by neutralizing harmful molecules directly. It appears to activate a cellular defense pathway that enhances your body’s own antioxidant enzymes, making cells more resilient to oxidative stress. This is relevant in conditions like stroke, traumatic brain injury, and neurodegenerative diseases where oxidative damage drives much of the harm.
In Alzheimer’s disease research, CBD has shown effects on a specific signaling pathway involved in the formation of the protein tangles that characterize the disease. It also slows the reabsorption of adenosine, a molecule that plays protective roles during oxygen deprivation, which has shown promise in models of neonatal brain injury. None of this has translated into approved treatments for neurological diseases yet, but it represents one of the more active areas of hemp-related medical investigation.
How Delivery Method Affects Absorption
How you take CBD dramatically changes how much of it actually reaches your bloodstream. Swallowing a capsule or edible delivers only about 9 to 13% of the CBD to your system, because the compound is water-resistant and gets heavily processed by your liver before reaching general circulation.
Placing CBD oil under your tongue (sublingual administration) roughly doubles that, reaching 12 to 35% bioavailability. Inhaling vaporized CBD offers the highest absorption at 31 to 45%, though it carries its own respiratory considerations. Topical creams and patches perform poorly, with only 1 to 10% reaching deeper tissue. Most of the CBD accumulates in the outermost skin layers without penetrating further.
These numbers matter practically. If you’re taking a 50 mg CBD capsule, your body may absorb as little as 4.5 mg. The same amount taken sublingually could deliver up to 17.5 mg. This partly explains why people report such different experiences with the same product at the same dose.
Side Effects and Drug Interactions
CBD is generally well-tolerated, but it is not side-effect-free, especially at therapeutic doses. In clinical trials, the most common adverse effects were digestive symptoms (reported in about 60% of CBD users versus 31% on placebo), drowsiness (17%), reduced appetite (17%), and elevated liver enzymes (13%). Diarrhea alone affected about 32% of participants.
The liver enzyme issue deserves attention. About 6.4% of people taking CBD in clinical trials experienced serious elevations in liver enzymes, compared to zero in the control groups. This signals liver stress and is the reason that patients on Epidiolex undergo regular liver function monitoring.
CBD also interacts with a family of liver enzymes responsible for processing many common medications. It can act as a competitor, inhibitor, or modifier of these enzymes, potentially raising or lowering the blood levels of other drugs you take. One well-documented example involves blood thinners: CBD can increase warfarin concentrations in the blood, raising the risk of bleeding. If you take prescription medications, this interaction profile is something to take seriously and discuss before adding CBD to your routine.
What’s Approved vs. What’s Available
The gap between approved and available is wide. The FDA has approved exactly one hemp-derived product: Epidiolex for epilepsy. Two other cannabis-related medications, Marinol/Syndros and Cesamet, are approved for AIDS-related appetite loss and chemotherapy nausea, but these contain synthetic versions of THC, not hemp-derived CBD. No other hemp or cannabis product has FDA approval for any condition in any patient population.
That said, millions of people use over-the-counter hemp-derived CBD for pain, anxiety, sleep, and inflammation. The 2018 Farm Bill legalized hemp cultivation, making these products widely accessible. The disconnect between consumer use and regulatory approval means product quality, labeling accuracy, and dosing consistency vary enormously. Pharmaceutical-grade CBD used in clinical trials is a very different product from many retail offerings, and the doses shown to work in studies (often 150 to 400 mg) are frequently higher than what commercial products provide per serving.